Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Low Dose Bortezomib on Bone Formation in Smoldering Myeloma Patients

NCT00983346 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT00983346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00983346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Low Dose Bortezomib on Bone Formation in Smoldering Myeloma Patients
Lead sponsor
University of Utah
Phase
Phase 2
Overall status
Terminated
Start date
October 31, 2009
Completion date
September 30, 2014
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, multiple myeloma, myeloma